Results 161 to 170 of about 23,000 (243)

Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases [PDF]

, 2015

core   +1 more source

CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications

BMC Nephrology
Objective Diabetic kidney disease (DKD) is increasingly recognized as a leading cause of chronic kidney disease (CKD) worldwide. Although N6-methyladenosine (m6A) mRNA modification is abundant in eukaryotes, its specific contribution to DKD pathogenesis ...
Meng Leilei, Huang Bin, Li Rui, Wenjie Wen   +3 more
doaj   +1 more source

The crosstalk between N6‐methyladenosine readers and neuroblastoma

Clinical and Translational Discovery
Background Neuroblastoma (NB) is a heterogeneous pediatric solid tumour strongly influenced by epigenetic modifications. Methods This review explores the role of N6‐methyladenosine (m6A) modifications and their readers in NB progression.
Liping Chen, Jing He, Zhenjian Zhuo
doaj   +1 more source

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases. [PDF]

J Innate Immun, 2023
Teng Y, Yi J, Chen J, Yang L.
europepmc   +1 more source

Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis

International Journal of General Medicine
Yanlu Wang, Sisi Ling, Hao Feng, Junkai Hua, Zhiyu Han, Renjie Chai Department of Cardiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, 510260, People’s Republic of ChinaCorrespondence: Renjie Chai ...
Wang Y, Ling S, Feng H, Hua J, Han Z, Chai R   +5 more
doaj  

N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review. [PDF]

Epigenetics, 2023
Zhang Y, Xu Y, Bao Y, Luo Y, Qiu G, He M, Lu J, Xu J, Chen B, Wang Y.   +9 more
europepmc   +1 more source

Mechanism of N6-methyladenosine (m6A)-mediated upregulation of LINC00958 in the growth of cervical cancer. [PDF]

Front Oncol
Li Y, Liu Z, Jin H.
europepmc   +1 more source

m6AConquer: a consistently quantified and orthogonally validated database for the N6-methyladenosine (m6A) epitranscriptome. [PDF]

Nucleic Acids Res
Zhao X, Ye H, He D, Liu H, Li T, Rigden DJ, Wei Z.   +6 more
europepmc   +1 more source

Retracted: The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma. [PDF]

Comput Math Methods Med, 2023
Methods In Medicine CAM.
europepmc   +1 more source

m6AHD: a new framework for identifying abnormal N6-methyladenosine (m6A) in heart diseases based on sequencing features. [PDF]

Front Genet
Lu J, Li Y, Hong Y, Liao D, Fang G.
europepmc   +1 more source